Clinical Trial Update: Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating cannabidiol for burnout and distress prevention in front-line health care workers dealing with COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burnout
• Post-traumatic Stress Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Sao Paulo | Conditions: Covid19, Burn Out | Phase 2, Phase 3 | Status: COMPLETED